Accenture has entered into a technology collaboration with Google Cloud with an objective to help life sciences companies advance the discovery, development, and delivery of their innovative therapies.
Alexion Pharmaceuticals has completed the acquisition of clinical-stage biopharmaceutical company Achillion Pharmaceuticals for around $930m.
HighRes Biosolutions and Novo Nordisk announced that they will collaborate to design a state-of-the-art robotic platform for high-throughput biologics engineering and characterisation.
The US Centers for Disease Control and Prevention (CDC) has reported the first case of 2019 Novel Coronavirus (2019-nCoV) in the US state of Washington following the return of a patient from China who tested positive to the virus.
Clarivate Analytics has agreed to acquire Decision Resources Group (DRG) from Piramal Enterprises in a deal valued at around $950m.
Civica Rx (Civica, Inc.) today announced it has signed a long-term agreement with Thermo Fisher Scientific to develop and manufacture medications with Civica as the owner of the regulatory pathway.
Merck has completed the acquisition of US-based biopharmaceutical company ArQule in a deal valued at around $2.7bn.
Twist Bioscience, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced a collaboration with Schrödinger, a company focused on transforming the way therapeutics are discovered with a physics-based computational platform, to bring the two companies’ technology platforms together to discover new antibody therapeutics against G-protein coupled receptor (GPCR) targets.
Astellas Pharma has signed a deal worth up to $897.5m with Adaptimmune Therapeutics to co-develop and co-commercialise stem-cell derived allogeneic CAR-T and TCR T-cell therapies for cancer.
BioMotiv, a mission-driven biopharma company, and Atomwise, the leader in using artificial intelligence (AI) for small molecule discovery, today announced a strategic collaboration to co-develop therapies.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.